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1. Introduction
Menstrual disruptions (MD) 
are one of the most misunder-
stood problems in modern gy-
necology. Over the past decade, 
there has been an increase in 
the frequency of MDs in wom-
en of reproductive age almost 
11 times in the world. In the 
structure of gynecological mor-
bidity, according to most au-
thors [1, 2], menstrual disorders 
account for about 60 % of all 
dishormonal disorders, and the 
frequency of early pregnancy 
loss in progesterone deficiency 
ranges from 67 % to 80 % [3]. 
According to data [4], LPD is 
registered in 46.6 % of women 
with infertility with a regular 
menstrual cycle and in 85 % 
with habitual miscarriage [4]. 
The term “luteal phase deficien-
cy” is introduced to describe 
conditions in which the level of 
endogenous progesterone does 
not provide the functional se-
cretory activity of the endome-
trium, which leads to disruption 
of the processes of implantation 
and development of the embryo. 
Reproductive health disorders 
of a woman can occur with any 
kind of hormonal imbalance: 
insufficiency or excess of estro-
gens, insufficiency or excess of 
androgens, violation of physio-
logical boundaries for the tropic 
hormones of the hypothalamus, 
hormones synthesized in the 
pancreas or the small intestine. 
Uniting for these conditions is 
absolute or relative deficiency of 
progesterone and the resulting 
violations of the structural-re-
ceptive potential of the endome-
trium and mucous membranes 
of the genital tract of women. 
The etiopathogenesis of LUF 
syndromes as well as LPD has not been fully studied. Today, 
the role of vitamin D deficiency in the formation of various 
endocrine imbalances and infertility is widely debated [5].
Aim of the research: study of the effect of vitamin D defi-
ciency and progesterone deficiency in the luteinized unruptured 
follicle syndrome (Geis-Genes) and the luteal phase deficiency 
on the reproductive potential of women.
2. Methods
Hormonal studies were carried out in the biochemical labo-
ratory of the Ukrainian scientific and practical center for endo-
crine surgery, transplantation of endocrine organs and tissues of 
the Ministry of Health of Ukraine.
The study design included 45 women with progesterone 
deficiency (main group):
1) 32 of them are with LPD 
and 13 are LUF. LPD markers 
were: dysfunction of the corpus 
luteum: the endometrium was 2 
or more days behind in its devel-
opment;
2) short luteal phase: less 
than 8 days from the peak of 
luteinizing hormone (LH), asso-
ciated with low levels of folli-
cle-stimulating hormone (FSH), 
impaired release of FSH and LH 
or FSH/LH ratio;
3) inadequate luteal phase 
with progesterone secretion less 
than normal. The markers of 
LUF syndrome – follicle per-
sistence – are established in the 
process of folliculometry as a 
progressive growth in the first 
phase of the antral follicle cycle 
to the size of a periovulatory 
and gradual reverse develop-
ment during the second phase 
to the initial value. In this case, 
LUF syndrome is manifested by 
a thickening and an increase 
in the echogenicity of the wall 
of the follicle against the back-
ground of cyclic changes in the 
thickness and echogenicity of the 
endometrium, characteristic of a 
two-phase cycle [8]. Ultrasound 
examination was performed on 
an Aloka Hitachi device (Japan) 
with a sensor frequency of 7 
MHz. A hormonal study was 
conducted in the 1st phase of the 
menstrual cycle (5–7 days) and 
on 21–24 days of the menstrual 
cycle. Chemiluminescent immu-
noassay was performed to deter-
mine FSH, LH, prolactin, pro-
gesterone, estradiol. The study 
of 25-hydroxyvitamin D (nmo-
l/l) was done with solid-phase 
enzyme-linked immunosorbent 
assay with Sunrise Tecan device 
(conducted in the DILA labo-
ratory). Reference standards – according to laboratory data. 
Correction of vitamin D was carried out according to the 
recommendations of the Endocrinological community [6].
The control group – 31 healthy women of reproductive age 
at the stage of preparation for pregnancy.
Statistical data processing was carried out on a personal 
computer using a standard software package of applied statisti-
cal analysis (Statistica for Windows v.6). using both parametric 
criteria (Student’s t-test) and non-parametric (Mann-Whit- 
ney χ2), Pearson correlation criteria, and regression analysis. 
3. Results
The average age of the examined main group was 20.3± 
±1.7 years, in the control group – 20.9±1.6 years. The average 
age of menarche for women in both groups was 13–14 years old 
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(13.3±0.34 in the main group and 13.0±0.23 in the control group 
(p>0.05)). Women of both groups were preparing for gestational 
debut. An analysis of the menstrual function of women in the 
main group in 15 (33.3 %) revealed the presence of menopaus-
al and painful menstruation, in 21 (46.7 %) a spotting in the 
perimenstrual period. The main indicator of the echographic 
structure of the corpus luteum of the ovaries and endometrium 
in women with LPD was an increase in the echogenicity of the 
M-echo in the peripheral regions with a hypoechoic zone in 
the center (noted in 29 (90.6 %). No secretory changes in the 
endometrium (21–24 days of the cycle) was characterized by the 
presence of its three-layer structure, typical for the pre-ovula-
tory period, with hypogenic functional layers (96.8 %). In 26 
(81.25 %) patients a decrease in <0.22 of the volume of the yellow 
body to the volume of the ovary was noted, in 6 (18.75 %) the 
yellow body was represented by the cystus cavity of a homoge-
neous internal structure with a high conductivity and a com-
pletely heterogeneous structure with small echoic inclusions. 
The wall thickness of the corpus luteum was 1.2±0.5 mm. For 
all women with LUF, a sonographic study showed a thickening 
and increase in the echogenicity of the wall of the follicle against 
the background of cyclic changes endometrial thickness and 
echogenicity characteristic of a two-phase cycle.
The study of hormonal background showed low levels of folli-
cle-stimulating hormone (FSH) in the first phase of the menstrual 
cycle at 3.45±1.23 U/l, which was significantly different from the 
control group 6.12±1.23 U/l, and 5.22±1.64 U/l at LUF (p<0.05). 
The ratio of FSH/LH in women with LPD was 0.83±0.13, with 
LUF 1.26±0.24, in the control group – 1.51±0.32. The level of 
prolactin also significantly exceeded these indicators in women 
of the control group, while it did not differ among women with 
LPD and LUF (with NLF: 15.25±1.73 ng/ml, with LUF: 14.15± 
±1.56 ng/ml control indicator 7.23±1.45 ng/ml). The analysis of 
the estradiol index at the beginning of the cycle was also different 
for LPD and LUF: 56.83±3.23 pg/ml for LPD; 79.27±12.21 pg/
ml and 89.27±12.21 pg/ml in the control group. Analysis of pro-
gesterone in women with LUF in the 1st phase of the menstrual 
cycle did not differ from the control group, at the same time with 
LPD – was reduced: 0.83±2.43 ng/ml with LPD, against 1.2± 
±0.92 ng/ml at LUF, and 1.1±0.12 ng/ml in the control group. 
In the second phase: with LPD 17.6±2.23 ng/ml, with LUF: 
14.15±1.56 ng/ml, and 23.12±11.23 ng/ml in the control group.
The level of prolactin in women of the main group was in-
creased in comparison with the control group 15.25±1.73 ng/ml 
against 10.23±1.45 ng/ml.
During the periconceptional supplementation, the patients 
were divided into groups: I-a: 15 patients with LPD and 13 with 
LUF (33 women), in addition to the generally accepted proges-
terone in the 2nd phase of the menstrual cycle, received vitamin 
D3 – in an individually selected dose – 3 months. I-b: 17 patients 
with LPD received traditional progesterone therapy (didroges-
terone 10 mg×2 times a day).
At the end of the 3-month therapy, an ultrasound, hormon-
al study and the determination of the level of vitamin D were 
performed.
The results of treatment are presented in Table 1.
Table 1
The results of the examination at the end of treatment
Indicator
Group І-а Group І-b Control group
5 day of the menstrual cycle 
before treatment
5 day of the menstrual 
cycle after treatment
5 day of the menstrual cycle before 
treatment
5 day of the 
menstrual cycle 
after treatment
5 day of the 
menstrual cycle 
FSH/LH 1.03±0.18 1.49±0.26 0.83 ±0.13 1.21±0.12 1.51±0.32 
Prolactin ng/ml 15.25±1.73 10.47±1.34* 13.25±1.16 12.67±0.98 10.23±1.45
Vit D nmol/l 18.23±1.73 45.34±1.35* 17.43±1.18 47.21±1.76* 53.25±2.43
Ovarian  
structure
Follicles with a diameter of 6–9 
mm with increased echogenicity 
of the wall of the follicle
Follicles with a diameter 
of 5–9 mm
Follicles with a diameter of 6–9 mm 
with an increase in the echogenicity 
of the wall of the follicle 
Follicles with a 
diameter of 
 6–9 mm
Follicles with a 





The thickness of the «M» echo 
3.4±1.17 mm with an increase 
in the echogenicity of the wall of 
the follicle
Proliferative 
The thickness of the «M» 
echo 3.21±1.11 mm
Proliferative 
The thickness of the «M» echo 
3.4±1.32 mm with an increase in 








of the «M» echo 
4.4±1.11 mm
21 day of the menstrual cycle 
before treatment
21 day of the menstrual 
cycle after treatment
21 day of the menstrual cycle before 
treatment
21 day of the 
menstrual cycle. 
after treatment
21 day of the 
menstrual cycle
Progesterone 
ng/ml 15.412±1.51* 22.6±2.56 17.6±2.23 18.12±12.23 23.12±11.23
Ovarian 
 structure
<0.22 decrease in the ratio of 
the volume of the corpus luteum 
to the volume of the ovary
the ratio of the volume 
of the yellow body to 
the volume of the ovary 
>0.22
<0.22 decrease in the ratio of the 
volume of the corpus luteus to the 
volume of the ovary and the corpus 
luteum was represented by the cystic 
cavity of a homogeneous internal 
structure with high conductivity and 
a completely heterogeneous struc-
ture with small echogenic inclusions
the ratio of the 
volume of the 
yellow body to 
the volume of 
the ovary >0.22 




increased echogenicity of 
M-echo in the peripheral regions 
with a hypoechoic zone in the 
center; with LUF, there are cyclic 
changes in the thickness and 
echogenicity of the endometrium
secretory transformation 
of the endometrium, lag 
of secretory transfor-
mation in 10 (79.8 %) 
patients
increased echogenicity of M-echo 
in the peripheral regions with a 
hypoechoic zone in the center;
lag of secretory 
transformation 
in 2 (11.8 %) 
patients
secretory trans-
formation of the 
endometrium
Note: * – p<0.05 – significantly in relation to the indicator of the control group
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4. Discussion
The inverse correlation dependence of the average force 
between the decrease in vitamin D level and the prolactin index 
(r=–0.28; p=0.03), the straight line between the vitamin D index 
and FSH (r=+0.31; p=0.01) was traced. In our opinion, these 
disorders in the follicular phase of the menstrual cycle lead to a 
decrease in the levels of estrogen and progesterone in the luteal 
phase.
An analysis of the ultrasound examination of patients with 
LUF after the end of the periconceptional supplementation 
demonstrated practically no difference in the structure of the 
ovaries with the control group, in 10 (79.8 %) the endometrium 
lagged behind its secretory transformation, this picture of the 
endometrium was probably caused not only by a decrease in 
progesterone secretion the corpus luteum of the ovaries, but also 
a disorder at the level of the endometrial receptor apparatus, 
which requires additional immunohistochemical studies of the 
endometrium in this cohort of patients [7, 9].
Thus, progesterone deficiency entails changes in various 
regulatory substances of the reproductive system, and there-
fore the periconceptional supplementation must be individu-
alized [10].
The introduction of the definition of vitamin D in the peri-
conceptional screening plan and its correction are justified and 
necessary to improve the structure of the endometrium and its 
secretory transformation in women with progesterone imbal-
ance. Similar conclusions came from other researchers [11].
Studying vitamin D receptor status in progesterone defi-
ciency may be promising when developing a periconceptional 
screening algorithm for patients with LPD and LUF.
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